ORLANDO – Noble, a developer of autoinjector, prefilled syringe, wearable and respiratory devices, has launched its connected device platform, AdhereIT, which is designed to help improve patient experiences and outcomes by providing real-time feedback for autoinjector training and injection sessions. “There has been a rapid growth of innovative treatments delivered through autoinjectors, which allow patients the convenience of self-administering the drug,” said Jeff Baker, CEO of Noble, in a statement. “Our priority is to help ensure that patients who self-inject feel confident they are using their devices correctly. We believe our new connected error-correcting device platform, with its array of smart features, can coach patients through training to administration at home.” AdhereIT promotes proper self-injection by sensing and monitoring how a patient interacts with the specific steps of drug delivery. It can detect when the device makes contact with the injection site on the skin, as well as the precise times at which a training session or an injection begins and ends. It can also send injection scheduling reminders to the patient when used in conjunction with an app. Adhere IT can wirelessly transmit the data it collects to a smartphone or tablet, and it has been configured to integrate with wireless platforms to enable the collection and customization of usage data. For pharmaceutical manufacturers, Adhere IT features a flexible form factor that allows it to fit onto trainers that closely mimic autoinjectors and onto a prescribed device itself.
You are here: / / Noble launches AdhereIT connected device platform